Pulling a page from ancient Rome’s military handbook, investigators in the DF/HCC Breast Cancer Program are deploying a divide-and-conquer strategy in the battle against... | [more]
Welcome to Dana-Farber/Harvard Cancer Center
Welcome to Dana-Farber/Harvard Cancer Center (DF/HCC) — the largest comprehensive cancer center in the world. Funded by a grant from the National Cancer Institute, we have joined seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal — to find new and innovative ways to combat cancer.Announcements
- Cancer Research Collaboration Committee Looking for New Members Posted: 06-16-08
- Advance Notice: Breast SPORE Competitive Renewal Posted: 06-09-08
- DF/HCC Member Survey Raffle Winners Posted: 06-05-08
Latest Cancer News
Divide-and-conquer strategy drives breast cancer breakthroughs
siRNA knockdowns turn up intriguing HER2 targets
At best, only 20 to 30 percent of women with HER2-positive breast cancer respond to trastuzumab. That grim reality has prompted the Breast Cancer Program to search for new... | [more]
Fusion vaccine plus surgery may prove potent combination in renal cell cancer
Renal cell cancer (RCC) is a life-threatening malignancy considered incurable in the metastatic setting. While standard chemotherapy has proved largely ineffective,... | [more]
Specialized Histopathology Services Core
The Specialized Histopathology Services (SHS) Core provides technical and professional pathology services in a variety of experimental organisms and human tissues. Specific... | [more]
